Leading Solutions for Newborn and Women’s Health
Delivering first-in-class medical devices and health management solutions for newborn and women’s health
We are E3A, a leading innovator in first-in-class medical devices and health management solutions for newborn and women’s healthcare. Founded on the campus of the National University of Singapore in 2019, we aim to leverage our experience in optoelectronics and bioengineering to deliver better solutions for newborn and women’s healthcare.
E3A Healthcare's innovative portfolio includes over 80 patented technologies, with its devices receiving clearance from the US FDA and Chinese NMPA (CFDA). Additionally, the company has garnered support from leading investors, including the National University of Singapore, Sequoia Hong Kong X Fund, SUNBO Angel Partners, and leading family offices, alongside notable financial support from both the Singaporean and Hong Kong governments.
Our Products
E3A develops first-in-class medical devices for newborn and women’s health, creating innovative solutions that addresses overlooked demands.
Our Partners
Our Investors and Sponsors
News
Media Coverage
Contact Us
We're eager to hear from you! Get in touch with us and let's explore how our partnership can together deliver better care for families worldwide.
